An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

The industry’s mRNA alliance is demanding steady FDA leadership, warning that the current “unprecedented turmoil” at the ...

Myths about mRNA vaccines and fertility persist despite rigorous studies debunking them.

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

As vaccine policy uncertainty reaches a new level in the U.S., the Centers for Disease Control and Prevention's (CDC’s) team ...

The rebound is well underway.

By 2025, more than 13 billion doses of the vaccine are estimated to have been administered globally, saving untold millions ...

Piper Sandler 37th Annual Healthcare Conference December 2, 2025 11:00 AM ESTCompany ParticipantsJames Mock - Chief ...

In the wake of the memo, several vaccine experts responded that the CBER director's claim about the deaths requires more ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become ...